Evidence map›Paper›PMID 40270949›Full record

ArticleClinical and translational radiation oncology2025

Multidisciplinary approach to target volume delineation in locally recurrent rectal cancer: An explorative study.

F Piqeur, D S C van Gruijthuijsen, J Nederend, H Ceha, T Stam, M Dieters, P Meijnen, M Bakker-van der Jagt, M Intven, A E Verrijssen and 18 more

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

F PiqeurDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
D S C van GruijthuijsenDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
J NederendDepartment of Radiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, Netherlands (the).
H CehaDepartment of Radiation Oncology, Haaglanden Medical Centre, Burg. Banninglaan 1, 2262AK Leidschendam, Netherlands (the).
T StamDepartment of Radiation Oncology, Haaglanden Medical Centre, Burg. Banninglaan 1, 2262AK Leidschendam, Netherlands (the).
M DietersDepartment of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, 9713GZ Groningen, Netherlands (the).
P MeijnenDepartment of Radiation Oncology, Amsterdam University Medical Centre, De Boelelaan 1118, 1081HZ Amsterdam, Netherlands (the).
M Bakker-van der JagtDepartment of Radiation Oncology, Amsterdam University Medical Centre, De Boelelaan 1118, 1081HZ Amsterdam, Netherlands (the).
M IntvenDepartment of Radiation Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584CX Utrecht, Netherlands (the).
A E VerrijssenDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
J S CnossenDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
M BerbeeDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Doctor Tanslaan 12, 6229ET Maastricht, Netherlands (the).
M den HartoghDepartment of Radiation Oncology, Radiotherapiegroep, Wagnerlaan 47, 6815AD Arnhem, Netherlands (the).
E J Bantema-JoppeRadiotherapeutisch Instituut Friesland, Borniastraat 36, 8934AD Leeuwarden, Netherlands (the).
M De KroonDepartment of Radiation Oncology, Zuidwest Radiotherapeutisch Instituut, Boerhaavelaan 19, 4078AE Roosendaal, Netherlands (the).
G PaardekooperDepartment of Radiation Oncology, Isala Zwolle, Dokter van Heesweg 2, 8025AB Zwolle, Netherlands (the).
M P M GielensDepartment of Radiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, Netherlands (the).
A W Daniels-GooszenDepartment of Radiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, Netherlands (the).
M J LahayeDepartment of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands (the).
D M J LambregtsDepartment of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands (the).
S A OeiDepartment of Radiology, Haaglanden Medical Centre, Burg. Banninglaan 1, 2262AK Leidschendam, Netherlands (the).
J B HouwersDepartment of Radiology, Maastricht University Medical Centre, P. Debeyelaan 25, 6229HX Maastricht, Netherlands (the).
K HorsthuisDepartment of Radiology, Amsterdam University Medical Centre, De Boelelaan 1118, 1081HZ Amsterdam, Netherlands (the).
C HurkmansDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
H RuttenGROW School of Oncology and Developmental Biology, University of Maastricht, Universiteitssingel 40, 6229ER Maastricht, Netherlands (the).
J W A BurgerDepartment of Surgery, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).
C A M MarijnenDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands (the).
H PeulenDepartment of Radiation Oncology, Catharina Hospital, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands (the).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Interobserver variation (IOV) in locally recurrent rectal cancer (LRRC) delineations is large, possibly because of different interpretations of imaging. An explorative study was performed to investigate the benefit of additional delineations by expert radiologists. Materials and methods: 14 cases of LRRC were delineated on planning CT by 8 radiologists (RADs) to construct a median and total radiology contour, followed by 12 radiation oncologists (ROs), without (GTV-) or with (GTV+) the additional contours. IOV was calculated separately for RADs, GTV- and GTV+. The following metrics were used: the Surface Dice Similarity Coefficient (SDSC), Dice similarity coefficient (DSC), and Hausdorff Distance at the 98th percentile (HD98%). The median SDSC, DSC, and HD98% of GTV- and GTV+ were compared. Sub-analyses of IOV in different recurrence types were performed. Results: Median SDSC significantly improved from GTV- to GTV+ overall, but a significant benefit could not be proven in individual cases. Additional radiological input consistently improved all parameters in 4/14 cases (29 %). Geographical miss occurred after radiological input in 7 %. Subgroup analyses show large IOV in mainly fibrotic and intraluminal recurrences. Little IOV is seen in solitary nodal recurrences. Conclusion: This study highlights target volume delineation challenges in LRRC. Overall, radiological input reduced IOV amongst ROs in target volume delineation for LRRC. Large differences do however exist amongst recurrence types. A standard terminology for LRRC and close collaboration between radiologists and radiation oncologists seems necessary to reduce IOV and improve quality of care.

Indexed as

Interobserver variationLocally recurrent rectal cancerMultidisciplinary collaborationTarget volume delineation

Identifiers

PMID40270949
PMCPMC12017975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.